The Governors of the University of Calgary
Date of Award
Crohn's Disease, Therapeutics
Term of Grant
Interleukin-4 Activated Macrophages (M(IL4)) for Personalized Cellular Immunotherapy to Treat IBD
This project aims to provide the groundwork for testing a new cell-based therapeutic derived from a patient’s own blood cells as a therapeutic option.